Integrating Guidelines and Clinical Trial Evidence Into Optimal Collaborative Care for Patients With Pulmonary Arterial Hypertension Learn More »
06.05.2013 The Treatment of Pulmonary Arterial Hypertension with the Anti-proliferative Agent Hydroxyurea Live Online Webinar
Pulmonary Arterial Hypertension have been shown to have similar characteristics with myeloproliferative disorders that are normally treated with hydroxyurea. NHLBI researcher Ronan Desmond, MD will discuss his group's hypothesis that hydroxyurea will improve hemodynamic parameters in PAH patients by looking at the effects in NOC/SCID mice in which the disease phenotype has been replicated. Learn More »
06.14.2013 PHA Preceptorship: Ann Arbor, Mich. University of Michigan Towsley Center
Sheldon Room G2310 (First Floor)
1500 East Medical Center Drive
Ann Arbor, Michigan
A Collaborative Approach for Clinicians on the Front Line Learn More »
06.06.2013 Yale 7th Annual Pulmonary Hypertension Symposium The Madison Beach Hotel
Madison, Conn.
Pulmonary hypertension (PH) is a commonly encountered finding on echocardiography for clinicians on the front lines. There is tremendous need for education of licensed care providers regarding how to evaluate patients with PH and the need for timely referral and treatment at centers specialized in this disorder. Systemic sclerosis associated pulmonary arterial hypertension (PAH) is a particularly challenging form of PAH to diagnose and manage. This course will review the proper diagnostic workup of patients with PH on an echo and will review the currently available PAH specific therapies. It will also examine the unique features of Systemic Sclerosis-Associated PAH and the cardiac adaptations that evolve in these patients. It will also discuss the outcomes of PH in Pregnancy and the approach to the intensive care management of right heart failure from severe PH.
IMPACT 2013, the preeminent event for PA-specific continuing medical education (CME) offers visitors the opportunity to connect with thousands of their peers from all practice areas. IMPACT 2013 concentrates on premium PA-specific programming presented by authorities who are experts in their fields. Learn More »
06.05.2013 - 06.08.2013 Thomas L. Petty Aspen Lung Conference Aurora, CO
56th Annual Meeting: Thomas L. Petty Aspen Lung Conference
"The Lung Microbiome: A New Frontier in Pulmonary Medicine" Learn More »
06.28.2013 - 06.30.2013 6th International Conference on cGMP Effectors and Therapeutic Implications Erfurt
This series is the leading conference in the field of the exciting and important signaling molecule, cGMP. Further breakthroughs in understanding of guanylate cyclase regulation and cGMP effector mechanisms have been made and will be discussed with all world experts being present. The pathophysiological and therapeutic implications including different cGMP-elevating drugs in clinical development are role models of translating basic science into the clinic. Learn More »
07.26.2013 - 07.29.2013 International Academy of Cardiology 18th World Congress on Heart Disease Hyatt Regency Vancouver Vancouver, BC, Canada
The International Academy of Cardiology, in affiliation with the California Chapter of the American College of Cardiology and the American Society for Preventive Cardiology, will hold the 18th World Congress on Heart Disease Annual Scientific Sessions. A comprehensive overview of research developments in cardiovascular medicine will be provided. The Scientific Sessions will cover topics including coronary artery disease, peripheral arterial disease, heart failure and more. Learn More »
08.18.2013 - 08.23.2013 Lung Development, Injury and Repair Proctor Academy
Andover, NH
Lung diseases such as chronic obstructive pulmonary disease, pulmonary fibrosis, bronchopulmonary dysplasia, acute and neonatal respiratory distress syndrome represent a huge global health problem, affecting more than 600 million people worldwide. While some of these lung diseases have an obvious developmental component, there is growing appreciation that processes and pathways critical for normal lung development are also important for postnatal tissue homeostasis and are dysregulated in lung disease. Learn More »
